Hall Render logo
THIS IS AN ADVERTISEMENT

health care uninterrupted.

  • Hall Render Advisory Services
  • COVID-19 Resources
MENU
  • About Us
    • Inclusion & Belonging Overview
    • Recognition
    • Firm Leadership
  • Services
  • Our People
    • Attorneys
    • Consultants
    • Administrative Team
  • Offices
      • AnchorageAnchorage Office

      • DallasDallas Office

      • DenverDenver Office
      • DetroitDetroit Office

      • IndianapolisIndianapolis Office

      • MilwaukeeMilwaukee Office
      • Raleigh Skyline _ 3000×1335Raleigh Office

      • D.C.Washington, D.C. Office
      • all-office-button
  • Resources
    • Articles
    • Firm News
    • Webinars
    • Presentations
    • Podcasts
  • Careers
  • Contact
  • About Us
    • Inclusion & Belonging Overview
    • Recognition
    • Firm Leadership
  • Services
  • Our People
    • Attorneys
    • Consultants
    • Administrative Team
  • Offices
    • [Column]
    • [Column]
    • [Column]
    • [Column]
  • Resources
    • Articles
    • Firm News
    • Webinars
    • Presentations
    • Podcasts
  • Careers
  • Contact
  • Hall Render Advisory Services
  • COVID-19 Resources

Pharmacy/PPE

  • Pharmacists’ Expanded Authority to Administer Childhood Vaccines: What to Know (October 6, 2020)
  • Eligible Outpatient Facilities of 340B Hospitals Can Now Bypass Registration Delays (June 5, 2020)
  • Hospitals Fear Pandemic May Threaten Their Eligibility to Participate in the 340B Drug Program (May 29, 2020)
  • PREP Act Immunity for Pharmacists Ordering COVID-19 Tests: New HHS OGC Advisory Opinion Addresses Conflicting State Laws (May 21, 2020)
  • Attention 340B Hospitals: CMS Cost Data Survey Due May 15 Raises Important Compliance Questions (May 1, 2020)
  • FDA Issues Sterile Compounding Pharmacy PPE Guidance (April 17, 2020)
  • FEMA Restricts Export of PPE in Temporary Final Rule (April 10, 2020)
  • A COVID-19 340B Update: OPA Updates Its GPO Prohibition Guidance and Other Outstanding 340B Program Issues (March 25, 2020)
  • USP Publishes Guidance on Conserving PPE in Sterile Compounding and Compounding Hand-Sanitizer During COVID-19 Pandemic (March 23, 2020)
  • COVID-19 Testing Update: Legal Considerations for Drive-Through Collection Sites, Diagnostic Testing Sites and Diagnostic Test Development (March 20, 2020)
Collapse Arrow
  • COVID-19 Resource Center
  • Post Acute & Long-Term Care
  • Reimbursement & Payment Programs
  • Telemedicine
  • Real Estate/M&A
  • Information Technology
  • Tax
  • Human Resources/Labor & Employment Issues
  • Antitrust
  • Government Investigations & FCA
  • Litigation
  • Finance
  • Immigration
  • Daily Briefings
  • FDA & Life Sciences
  • Fraud & Abuse
  • M&A
  • Physician Alignment
  • Accreditation
  • State-Specific Information
  • OIG Guidance

Connect With Us

Facebook Icon RSS Icon
  • About Us
  • Services
  • Our People
  • Offices
  • Resources
  • NTRACTS
  • Careers
  • Contact
  • Accessibility
  • Hall Render Title Support Services
  • Articles
  • Firm News
  • Presentations
  • Webinars
  • Health Industry News
  • Firm Brochure
Sign up to receive Hall Render alerts on topics related to health care law.

Connect With Us

Twitter Link LinkedIn Link Facebook Link RSS Link

LEGAL NOTICES & PRIVACY POLICY

© 2002-2025. Hall, Render, Killian, Heath & Lyman, P.C. All Rights Reserved.